Roche Licenses Simcere’s Tri-Specific Antibody SIM0660
Nanjing, China, September 1, 2026 Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, has entered into an exclusive global...
Blood Test
Advertisement
Cizzle Bio Study Supports CIZ1B for Early Lung Cancer
Dallas, Texas, September 1, 2026 Cizzle Bio, Inc. has announced the publication of a new peer-reviewed study providing additional...
Implantica Wins FDA Approval for RefluxStop® in U.S.
Stockholm, Sweden, August 21, 2026 Implantica AG has announced a major U.S. regulatory milestone after the U.S. Food and...
C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing
NEW YORK, August 21, 2026 The U.S. Food and Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2 blood test,...
C2N Diagnostics Expands PrecivityAD2 Use in UK Alzheimer’s Diagnosis
ST. LOUIS, July 29, 2026 C2N Diagnostics, LLC announced that researchers in the United Kingdom are integrating its PrecivityAD2®...
Advertisements
Guardant Health Launches Patrick Dempsey Campaign for CRC Screening
PALO ALTO, Calif., July 28, 2026 Guardant Health, Inc. has launched a new colorectal cancer (CRC) awareness campaign featuring...
GRAIL Teams with Priority Health to Expand Galleri
MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the Galleri®...
AAIC 2026 Study Shows Blood Test Predicts Alzheimer’s Risk
LONDON, United Kingdom, July 15, 2026 New research presented at the Alzheimer’s Association International Conference (AAIC) 2026 has revealed...
Freenome Reports Strong SimpleScreen CRC Study Results
BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...
Roche Receives CE Mark for Elecsys IGRA TB Test
BASEL, Switzerland, July 9, 2026 Roche has announced that its Elecsys IGRA TB blood test has received CE Mark...
Advertisement
